Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2017 07:00 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 25, 2017 at 9:00 AM EDT; Webcast Will be Available

GAITHERSBURG, Md., May 11, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 25, 2017 beginning at...
May 10, 2017 09:25 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and Manufacturing in Baltimore

GAITHERSBURG, Md., May 10, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today held a ribbon-cutting ceremony led by Dr. Rick Bright, director of the Biomedical Advanced Research...
May 09, 2017 07:00 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions to Unveil its Expanded Center for Innovation in Advanced Development and Manufacturing Supported through Public-Private Partnership with BARDA

ADVISORY, May 09, 2017 (GLOBE NEWSWIRE) -- WHO:Emergent BioSolutions Inc. (NYSE:EBS) WHAT:Ribbon-cutting and tour of expanded Emergent BioSolutions’ Center...
May 04, 2017 16:15 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance

GAITHERSBURG, Md., May 04, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and three months ended March 31, 2017. FINANCIAL HIGHLIGHTS ...
April 20, 2017 07:00 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call on May 4, 2017

GAITHERSBURG, Md., April 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 4, 2017 at 5:00 pm (Eastern Time) to discuss the financial...
March 31, 2017 07:00 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of Botulism Antitoxin

GAITHERSBURG, Md., March 31, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a modification to its contract with the Biomedical Advanced Research...
March 17, 2017 07:00 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions Awarded $100 Million BARDA Contract for BioThrax Deliveries to the Strategic National Stockpile

GAITHERSBURG, Md., March 17, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a two-year contract with the Biomedical Advanced Research and...
February 23, 2017 16:15 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms 2017 Guidance and Provides 2020 Goals

GAITHERSBURG, Md., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and twelve months ended December 31, 2016. 2016 FINANCIAL...
February 13, 2017 07:00 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral Hemorrhagic Fever Therapeutics

GAITHERSBURG, Md., Feb. 13, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has received a task order from the Biomedical Advanced Research and Development...
February 09, 2017 07:00 ET | Source: Emergent BioSolutions Inc.

Emergent BioSolutions to Release Fourth Quarter and Full Year 2016 Financial Results and Conduct a Conference Call on February 23, 2017

GAITHERSBURG, Md., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 23, 2017 at 5:00 pm (Eastern Time) to discuss the...